Introduction and Objective: Obesity is a serious health issue for Indigenous Americans residing in Arizona and genetic factors are believed to play a role in the development of this chronic disease. The aim of this study was to identify and mechanistically study variants that associate with BMI. We identified 3 variants associated with BMI located […]
Read MoreAuthor: sugaradmin
Why People Using GLP-1s Are Less Likely to Exercise
Share on PinterestRecent research has found that despite the benefits, people using GLP-1s may be less likely to exercise. Image Credit: Fiordaliso/Getty Images A recent study found that people taking a GLP-1 medication, like Ozempic or Wegovy, may be less likely to engage in regular exercise. The study showed that, among people with obesity, daily […]
Read More1220-OR: Survodutide: Differentiated GLP-1R and Glucagon Receptor (GCGR) Pharmacology Compared with Endogenous Ligands via Time-Resolved Assays
Introduction and Objective: Survodutide, a dual glucagon/GLP-1 receptor agonist in phase 3 trials for obesity and metabolic dysfunction-associated steatohepatitis, contains a C18-diacid half-life extension (HLE) group for once weekly dosing. This study thoroughly investigated the in vitro receptor pharmacology of survodutide and the impact of its HLE using time-resolved cellular assays.Methods: GCGR and GLP-1R both […]
Read More1184-OR: Women with Gestational Diabetes (GDM) on a Higher–Complex Carbohydrate (CHO) Diet Show Lower Postpartum OGTT Glucose
Introduction and Objective: GDM dietary therapy targets maternal glycemia in gestation but fails to address postpartum metabolic disease risk. In an RCT, pregnant women on a higher-complex CHO diet showed an improved OGTT response at 36 wks’. We studied the diets’ sustained effect 2 mos postpartum (PP).Methods: At diagnosis, women with diet-managed GDM were randomized […]
Read More1193-OR: Discovery and Characterization of New GLT-1 Autoreactive T Cells in Type 1 Diabetes
Introduction and Objective: The hallmark of T1D is the destruction of pancreatic insulin producing β-cells by autoreactive T cells. The quest for new antigen-specific autoreactive cells as well as for strategies that may target them are highly required to provide a more successful therapeutic option for T1D. Starting from many evidence suggesting a potential role […]
Read More1188-OR: Metformin Use during Pregnancy Influences Offspring Skeletal Muscle Metabolism in Juvenile Rhesus Macaques
Introduction and Objective: Metformin is an increasingly common medication used in pregnancy. However, metformin crosses the placenta raising concerns about unintended long-term effects to offspring health. This study examined whether metformin exposure during early development alters skeletal muscle metabolism in juvenile offspring and increases the risk of insulin resistance and obesity.Methods: Adult female Rhesus macaques […]
Read More1201-OR: Harmine and Exendin-4 Combination Attenuates Human β-Cell Senescence
Introduction and Objective: Harmine (H) plus Exendin-4 (E) robustly enhances human β cell regeneration, yet whether H+E influences human β cell senescence is unknown. We developed a computational framework to resolve senescence heterogeneity in scRNA-seq and applied it to test whether H+E modulates senescence programs in cytokine-challenged vs. unchallenged human islets.Methods: We developed a machine-learning […]
Read More1217-OR: ApoC3 Inhibitor Olezarsen Markedly Reduces Triglycerides and Risk of Pancreatitis in Severe Hypertriglyceridemia Patients with Diabetes Mellitus: Insights from CORE-TIMI 72a and CORE2-TIMI 72b
Introduction and Objective: We assessed the efficacy of olezarsen, an antisense oligonucleotide targeting APOC3, in pts with severe hypertriglyceridemia (sHTG) and DM.Methods: The phase 3 RCTs CORE-TIMI 72a (N=617) and CORE2-TIMI 72b (N=446) randomized pts with sHTG (TG ≥500mg/dL) 1:1:1 to SC olezarsen 50mg, 80mg, or placebo Q4W for 12 mths. The primary endpoint was […]
Read More1262-OR: Type 1 Diabetes Multiancestry Polygenic Score (T1D MAPS) Is a Robust Predictor of Type 1 Diabetes Risk across Diverse Populations
Introduction and Objective: Polygenic scores (PS) are powerful predictors of type 1 diabetes (T1D) risk, but their performance can differ substantially across ancestries, highlighting the need for rigorous evaluation in different populations. In this study, we evaluated the performance of several established PS to predict T1D risk across ancestries in four biobanks: All of Us […]
Read More1248-OR: Triglycerides in Low-Density Lipoprotein and Coronary Artery Disease Risk: Evidence from Mendelian Randomization
Introduction and Objective: Triglyceride in low-density lipoprotein (TG-LDL) was considered a novel biomarker for coronary artery disease (CAD) from observational studies. We aimed to explore the causal relationship between TG-LDL levels and both overall and sex-specific CAD risk in individuals of European ancestry.Methods: We analyzed 487,759 European-ancestry participants from the UK Biobank and performed a […]
Read More